Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit Review0829 has been discontinued.
View all Non-selective Adrenergic β Receptors products.Pronethalol hydrochloride is an β-adrenergic antagonist, clinically effective in the treatment of angina pectoris and some arrhythmias.
Sold with the permission of AstraZeneca UK Ltd.
M. Wt | 265.78 |
Formula | C15H19NO.HCl |
Storage | Store at RT |
Purity | ≥99% (HPLC) |
CAS Number | 51-02-5 |
PubChem ID | 60975 |
InChI Key | QONLGXRPRAIDGI-UHFFFAOYSA-N |
Smiles | Cl.CC(C)NCC(O)C1=CC=C2C=CC=CC2=C1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
References are publications that support the biological activity of the product.
Main (1990) α-Adrenergic receptors. Comprehensive Medicinal Chemistry. Ed Hansch 3 187
Merck Index 12 7974
Keywords: Pronethalol hydrochloride, Pronethalol hydrochloride supplier, β-adrenoceptor, beta-adrenoceptors, β-adrenergic, beta-adrenergic, b-adrenoceptors, b-adrenergic, antagonists, Receptors, Non-Selective, ICI38174, AstraZeneca, ICI-38174, Non-selective, Adrenergic, Beta, 0829, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for Pronethalol hydrochloride include:
Kaya et al (2009) Coupling of β2-adrenoceptors to XLαs and Gαs: a new insight into ligand-induced G protein activation. J Pharmacol Exp Ther 329 350 PMID: 19144685
There are currently no reviews for this product. Be the first to review Pronethalol hydrochloride and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.